Cargando…

The molecular implications of a caspase-2-mediated site-specific tau cleavage in tauopathies

Detalles Bibliográficos
Autores principales:	Liu, Peng, Ashe, Karen H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328769/ https://www.ncbi.nlm.nih.gov/pubmed/33510072 http://dx.doi.org/10.4103/1673-5374.306073

Ejemplares similares

A simple human cell model for TAU trafficking and tauopathy-related TAU pathology
por: Bell, Michael, et al.
Publicado: (2021)

Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
por: Fuster-Matanzo, Almudena, et al.
Publicado: (2018)

A long story for a short peptide: therapeutic efficacy of a cleavage-specific tau antibody
por: Amadoro, Giuseppina, et al.
Publicado: (2021)

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
por: Trojanowski, John Q
Publicado: (2013)

What triggers tauopathy in chronic traumatic encephalopathy?
por: Chen, Liam
Publicado: (2018)

Transcellular Spreading of Tau in Tauopathies
por: Demaegd, Koen, et al.
Publicado: (2018)

Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice
por: Gamache, Julia, et al.
Publicado: (2019)

The Emergence of the Spike Furin Cleavage Site in SARS-CoV-2
por: Chan, Yujia Alina, et al.
Publicado: (2021)

Gender-Specific Expression of Ubiquitin-Specific Peptidase 9 Modulates Tau Expression and Phosphorylation: Possible Implications for Tauopathies
por: Köglsberger, Sandra, et al.
Publicado: (2016)

Ion Channel Formation by Tau Protein: Implications for Alzheimer’s Disease and Tauopathies
por: Patel, Nirav, et al.
Publicado: (2015)

Activity-dependent tau cleavage by caspase-3 promotes neuronal dysfunction and synaptotoxicity
por: Opland, Carli K., et al.
Publicado: (2023)

SVM-based prediction of caspase substrate cleavage sites
por: Wee, Lawrence JK, et al.
Publicado: (2006)

Are Tau Aggregates Toxic or Protective in Tauopathies?
por: Cowan, Catherine M., et al.
Publicado: (2013)

NMR Studies of Tau Protein in Tauopathies
por: Kitoka, Kristine, et al.
Publicado: (2021)

Tau exon 10 alternative splicing and tauopathies
por: Liu, Fei, et al.
Publicado: (2008)

Targeting tauopathy with engineered tau-degrading intrabodies
por: Gallardo, Gilbert, et al.
Publicado: (2019)

Site-specific phosphorylation and caspase cleavage of GFAP are new markers of Alexander disease severity
por: Battaglia, Rachel A, et al.
Publicado: (2019)

The Link Between Tau and Insulin Signaling: Implications for Alzheimer’s Disease and Other Tauopathies
por: Gonçalves, Rafaella Araujo, et al.
Publicado: (2019)

Pripper: prediction of caspase cleavage sites from whole proteomes
por: Piippo, Mirva, et al.
Publicado: (2010)

Abolishing Tau cleavage by caspases at Aspartate(421) causes memory/synaptic plasticity deficits and pre-pathological Tau alterations
por: Biundo, F, et al.
Publicado: (2017)

Glial Tau Pathology in Tauopathies: Functional Consequences
por: Kahlson, Martha A., et al.
Publicado: (2016)

The Role of Microglia in the Spread of Tau: Relevance for Tauopathies
por: Perea, Juan R., et al.
Publicado: (2018)

Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies
por: Ferrer, Isidro, et al.
Publicado: (2019)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
por: Rawat, Priyanka, et al.
Publicado: (2022)

STOP Codon Mutations at Sites of Natural Caspase Cleavage Are Implicated in Autism and Alzheimer’s Disease: The Case of ADNP
por: Gozes, Illana, et al.
Publicado: (2022)

A soluble tau fragment generated by caspase-2 is associated with dementia in Lewy body disease
por: Smith, Benjamin R., et al.
Publicado: (2019)

VPS35 regulates tau phosphorylation and neuropathology in tauopathy
por: Vagnozzi, Alana N., et al.
Publicado: (2021)

AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy
por: Ising, Christina, et al.
Publicado: (2017)

Delta-secretase (AEP) mediates tau-splicing imbalance and accelerates cognitive decline in tauopathies
por: Wang, Zhi-Hao, et al.
Publicado: (2018)

A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington’s disease patients
por: Liu, Peng, et al.
Publicado: (2019)

TBK1 interacts with tau and enhances neurodegeneration in tauopathy
por: Abreha, Measho H., et al.
Publicado: (2021)

Correction: Abolishing Tau cleavage by caspases at Aspartate(421) causes memory/synaptic plasticity deficits and pre-pathological Tau alterations
por: Biundo, F., et al.
Publicado: (2018)

Tau exhibits unique seeding properties in globular glial tauopathy
por: Chung, Dah-eun Chloe, et al.
Publicado: (2019)

Caspase-mediated cleavage of the centrosomal proteins during apoptosis
por: Seo, Mi Young, et al.
Publicado: (2018)

Threonine(175), a novel pathological phosphorylation site on tau protein linked to multiple tauopathies
por: Moszczynski, Alexander J., et al.
Publicado: (2017)

Endoproteolytic cleavage as a molecular switch regulating and diversifying prion protein function
por: Haigh, Cathryn L., et al.
Publicado: (2016)

A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
por: Giacomini, Caterina, et al.
Publicado: (2018)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
por: Laurent, Cyril, et al.
Publicado: (2018)

Colocalization of BRCA1 with Tau Aggregates in Human Tauopathies
por: Kurihara, Masanori, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_abhs1ujsloijd1gjusj2jgtqse